Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Machin PA"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hornigold K; Signalling Programme, Babraham Institute, Cambridge, United Kingdom., Baker MJ; Signalling Programme, Babraham Institute, Cambridge, United Kingdom.; Cell Signalling Group, Cancer Research UK Manchester Institute, University of Manchester, Macclesfield, United Kingdom., Machin PA; Signalling Programme, Babraham Institute, Cambridge, United Kingdom., Chetwynd SA; Signalling Programme, Babraham Institute, Cambridge, United Kingdom., Johnsson AK; Signalling Programme, Babraham Institute, Cambridge, United Kingdom., Pantarelli C; Signalling Programme, Babraham Institute, Cambridge, United Kingdom., Islam P; Signalling Programme, Babraham Institute, Cambridge, United Kingdom., Stammers M; Babraham Institute, Cambridge, United Kingdom., Crossland L; Signalling Programme, Babraham Institute, Cambridge, United Kingdom., Oxley D; Mass Spectrometry Facility, Babraham Institute, Cambridge, United Kingdom., Okkenhaug H; Imaging Facility, Babraham Institute, Cambridge, United Kingdom., Walker S; Imaging Facility, Babraham Institute, Cambridge, United Kingdom., Walker R; Flow Cytometry Facility, Babraham Institute, Cambridge, United Kingdom., Segonds-Pichon A; Bioinformatics Facility, Babraham Institute, Cambridge, United Kingdom., Fukui Y; Division of Immunogenetics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan., Malliri A; Cell Signalling Group, Cancer Research UK Manchester Institute, University of Manchester, Macclesfield, United Kingdom., Welch HCE; Signalling Programme, Babraham Institute, Cambridge, United Kingdom.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Nov 21; Vol. 14, pp. 1223653. Date of Electronic Publication: 2023 Nov 21 (Print Publication: 2023).
Autor:
Machin PA; Signalling Programme, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom., Johnsson AE; Signalling Programme, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom., Massey EJ; Signalling Programme, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom., Pantarelli C; Signalling Programme, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom., Chetwynd SA; Signalling Programme, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom., Chu JY; Signalling Programme, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom., Okkenhaug H; Imaging Facility, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom., Segonds-Pichon A; Bioinformatics Facility, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom., Walker S; Imaging Facility, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom., Malliri A; Cell Signalling, Cancer Research UK Manchester Institute, Manchester, United Kingdom., Fukui Y; Division of Immunogenetics, Department of Immunobiology and Neuroscience, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan., Welch HCE; Signalling Programme, The Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Jun 13; Vol. 14, pp. 1180886. Date of Electronic Publication: 2023 Jun 13 (Print Publication: 2023).
Autor:
Hornigold K; Signalling Programme, The Babraham Institute, Cambridge, United Kingdom., Chu JY; Signalling Programme, The Babraham Institute, Cambridge, United Kingdom., Chetwynd SA; Signalling Programme, The Babraham Institute, Cambridge, United Kingdom., Machin PA; Signalling Programme, The Babraham Institute, Cambridge, United Kingdom., Crossland L; Signalling Programme, The Babraham Institute, Cambridge, United Kingdom., Pantarelli C; Signalling Programme, The Babraham Institute, Cambridge, United Kingdom., Anderson KE; Signalling Programme, The Babraham Institute, Cambridge, United Kingdom., Hawkins PT; Signalling Programme, The Babraham Institute, Cambridge, United Kingdom., Segonds-Pichon A; Bioinformatics Facility, The Babraham Institute, Cambridge, United Kingdom., Oxley D; Proteomics Facility, The Babraham Institute, Cambridge, United Kingdom., Welch HCE; Signalling Programme, The Babraham Institute, Cambridge, United Kingdom.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Aug 24; Vol. 13, pp. 888415. Date of Electronic Publication: 2022 Aug 24 (Print Publication: 2022).
Autor:
Machin PA; Signalling Programme, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK., Tsonou E; Signalling Programme, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK.; Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Cambridge CB22 3AT, UK., Hornigold DC; Bioscience Metabolism, Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM), BioPharmaceuticals R&D, AstraZeneca, Cambridge CB22 3AT, UK., Welch HCE; Signalling Programme, The Babraham Institute, Babraham Research Campus, Cambridge CB22 3AT, UK.
Publikováno v:
Cells [Cells] 2021 Apr 16; Vol. 10 (4). Date of Electronic Publication: 2021 Apr 16.
Publikováno v:
The Biochemical journal [Biochem J] 1978 Aug 01; Vol. 173 (2), pp. 607-16.
Publikováno v:
Journal of molecular biology [J Mol Biol] 1974 Sep 15; Vol. 88 (2), pp. 349-71.
Publikováno v:
The Biochemical journal [Biochem J] 1979 Jul 01; Vol. 181 (1), pp. 21-36.
Autor:
Hajdu J, Machin PA, Campbell JW, Greenhough TJ, Clifton IJ, Zurek S, Gover S, Johnson LN, Elder M
Publikováno v:
Nature [Nature] 1987 Sep 10-16; Vol. 329 (6135), pp. 178-81.